Advertisement
New Zealand markets closed
  • NZX 50

    11,682.39
    -89.42 (-0.76%)
     
  • NZD/USD

    0.6127
    +0.0005 (+0.09%)
     
  • NZD/EUR

    0.5732
    +0.0018 (+0.32%)
     
  • ALL ORDS

    8,039.90
    +27.80 (+0.35%)
     
  • ASX 200

    7,796.00
    +26.60 (+0.34%)
     
  • OIL

    81.27
    -0.02 (-0.02%)
     
  • GOLD

    2,375.90
    +6.90 (+0.29%)
     
  • NASDAQ

    19,752.30
    -156.56 (-0.79%)
     
  • FTSE

    8,196.65
    -75.81 (-0.92%)
     
  • Dow Jones

    39,134.76
    +299.90 (+0.77%)
     
  • DAX

    18,146.28
    -107.90 (-0.59%)
     
  • Hang Seng

    18,028.52
    -306.80 (-1.67%)
     
  • NIKKEI 225

    38,596.47
    -36.55 (-0.09%)
     
  • NZD/JPY

    97.3500
    +0.1300 (+0.13%)
     

The Zacks Analyst Blog Highlights NVIDIA, Advanced Micro Devices, Stryker, Canadian National Railway and Target

For Immediate Release

Chicago, IL – September 19, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corp. NVDA, Advanced Micro Devices, Inc. AMD, Stryker Corp. SYK, Canadian National Railway Co. CNI and Target Corp. TGT.

Here are highlights from Monday’s Analyst Blog:

Top Research Reports for NVIDIA, AMD and Stryker

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., Advanced Micro Devices, Inc. and Stryker Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

NVIDIA shares have lost some ground lately, but their performance this year is in a league of its own for a company of this size. The stock is up +200% this year, which compares to the Zacks Tech sector's +36.9% gain and the S&P 500 index's +17.1%. Driving this outperformance is strong growth of artificial intelligence (AI), high-performance computing and accelerated computing, which is boosting its Compute & Networking revenues.

The datacenter end-market business is likely to benefit from the growing demand for generative AI and large language models using GPUs based on NVIDIA Hopper and Ampere architectures. A surge in Hyperscale demand and a solid uptake of AI-based smart cockpit infotainment solutions are acting as tailwinds.

Collaboration with Mercedes-Benz and Audi is likely to advance its presence in autonomous vehicles and other automotive electronics space. However, NVDA's near-term prospects are likely to be hurt by weakening demand for chips used in the professional visualization end market.

(You can read the full research report on NVIDIA here >>>)

Shares of AMD have outperformed the Zacks Electronics - Semiconductors industry over the year-to-date period (+57.1% vs. +40.9%). The company is benefiting from the growing adoption of fourth-generation EPYC. Genoa adoption has been strong in the second quarter of 2023, with deployments from the likes of Microsoft, AWS, Alibaba and Oracle.

Availability of Bergamo is crucial as a number of server providers like Dell, HPE, Lenovo and Supermicro are set to launch their new Bergamo-based platforms in the third quarter. AMD continues to benefit from acquisitions, including Xilinx and Pensando, which has diversified its business.

However, weakness in the Gaming and Embedded segment revenues are expected to hurt top-line growth. For 2023, the Zacks analyst estimates the Gaming segment to be pegged at $6.55 billion, indicating a decline of 3.8% year over year.

(You can read the full research report on AMD here >>>)

Stryker shares have outperformed the Zacks Medical - Products industry over the year-to-date period (+19.3% vs. -2.8%). The company witnessed strong performance across its segments in the United States. Strong International sales also buoy optimism. The momentum is expected to continue into the second half of 2023 on the back of ongoing procedural recovery and a strong order book for capital equipment.

Stryker's prospects in 2023 seem promising on the back of strong customer demand for its existing products as well as new launches. The company's guidance for earnings and revenues appears encouraging. A solid solvency position is a plus.

However, inflationary pressure and supply-chain challenges continue to plague Stryker. Stiff competition in the MedTech space remains a woe. Contraction in both gross and operating margin is a woe.

(You can read the full research report on Stryker here >>>)

Other noteworthy reports we are featuring today include Canadian National Railway Co. and Target Corp.

ADVERTISEMENT

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                       

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report

Target Corporation (TGT) : Free Stock Analysis Report

Canadian National Railway Company (CNI) : Free Stock Analysis Report

Stryker Corporation (SYK) : Free Stock Analysis Report

NVIDIA Corporation (NVDA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research